| Literature DB >> 32873194 |
Sathya N Thulasi Raman1, Elyse Latreille1, Jun Gao1, Wanyue Zhang1,2, Jianguo Wu1, Marsha S Russell1, Lisa Walrond1, Terry Cyr1, Jessie R Lavoie1, David Safronetz3, Jingxin Cao3, Simon Sauve1, Aaron Farnsworth1, Wangxue Chen4, Pei-Yong Shi5, Youchun Wang6, Lisheng Wang2, Michael Rosu-Myles1,2, Xuguang Li1,2.
Abstract
Zika virus (ZIKV) infection is a serious public threat with cases reported in about 70 countries and territories. One of the most serious consequences of ZIKV infection is congenital microcephaly in babies. Congenital microcephaly has been suggested to result from infection of neural progenitor cells (NPCs) in the developing fetal brain. However, the molecular and cellular mechanisms underlying microcephaly development remains to be fully elucidated. In this study, we employed quantitative proteomics to determine protein expression profile that occur during viral replication in NPCs. Bioinformatics analysis of the protein expression changes resulted in the identification of a wide range of cell signaling pathways. Specifically, pathways involved in neurogenesis and embryonic development were markedly altered, along with those associated with cell cycle, apoptosis, lipid metabolism and oxidative stress. Notably, the differential regulation of Ephrin Receptor and PPAR signaling pathways, as revealed by quantitative proteomics and validated by qPCR array, underscores the need to explore these pathways in disease development. Collectively, these results indicate that ZIKV-induced pathogenesis involves complex virus-host reactions; the findings reported here could help shed light on the mechanisms underlying ZIKV-induced microcephaly and ZIKV replication in NPCs.Entities:
Keywords: Ephrin signaling; Neural progenitor cells; PPAR signaling; ZIKV; ingenuity pathway analysis; proteomics
Mesh:
Substances:
Year: 2020 PMID: 32873194 PMCID: PMC7534353 DOI: 10.1080/22221751.2020.1818631
Source DB: PubMed Journal: Emerg Microbes Infect ISSN: 2222-1751 Impact factor: 7.163
Figure 1.ZIKV productively infects iPSC-derived NPCs. (a) NPCs were immunostained with primary (1°) antibodies against NPC markers SOX2 (red) and Nestin (green) (Top panel) or Pax6 (red) (bottom panel). As a negative control, NPC cells were immunostained with secondary (2°) antibodies alone. The nuclei were visualized using DAPI (blue). Scale bar is 200 µm. (b) NPC cells were infected with ZIKV at a MOI of 5 in triplicates and cell culture supernatant collected at 12 h, 24 h, 48 h and 72 hpi. Mean virus titers determined by plaque forming assay and the corresponding standard deviations as error bars are plotted in the graph. (c) Virus replication in ZIKV-infected NPCs was monitored by staining the infected cells at various time points with antibodies against the virus envelope protein (red) and double stranded (ds) RNA (green). Nuclei were visualized using DAPI (blue). Scale bar is 200 µm.
Top differentially regulated host proteins affected by infection at 24 and 48 hpi.
aFold change in expression in infected cell lysate when compared to mock infected cell lysate.
Figure 2.Volcano plot and canonical pathways identified by IPA using the protein expression dataset. (a) Fold change protein expression and the associated p-values of the 24 and 48 hpi dataset were plotted to obtain a Volcano plot. Proteins with significant p-values and with a fold change value ≥+1.2 or ≤−1.2 are highlighted. (b & c) IPA was used to identify the Canonical cellular pathways represented by the differentially expressed proteins in ZIKV-infected cell lysates collected at 24 and 48 hpi. The data from IPA Canonical pathway analysis were used to plot a graph of the activation state (z-score) and significance (-log(p) value) of the pathways represented by the (b) 24 hpi dataset and (c) 48 hpi dataset using GraphPad Prism (version 7). Pathways that are activated have a positive z-score and repressed pathways have a negative z-score. The Threshold of z<−1 and z>1 that we set for selection of activated and repressed pathways for further analysis is displayed as a dotted line in the graph.
GO enrichment analysis of top differentially expressed proteins at 24 hpi.
| GO biological process complete | Reference lista | Fold enrichment | Raw | FDRc |
|---|---|---|---|---|
| Cell morphogenesis involved in differentiation (GO:0000904) | 562 | 16.7 | 1.04E-09 | 8.25E-06 |
| Cell morphogenesis (GO:0000902) | 721 | 14.46 | 3.51E-10 | 5.60E-06 |
| Axonogenesis (GO:0007409) | 378 | 13.79 | 2.50E-05 | 3.32E-02 |
| Neuron projection morphogenesis (GO:0048812) | 490 | 12.77 | 5.10E-06 | 1.16E-02 |
| Plasma membrane bounded cell projection Morphogenesis (GO:0120039) | 494 | 12.66 | 5.34E-06 | 1.06E-02 |
| Axon development (GO:0061564) | 412 | 12.65 | 3.76E-05 | 4.00E-02 |
| Cellular component morphogenesis (GO:0032989) | 825 | 12.64 | 1.28E-09 | 6.79E-06 |
| Cell projection morphogenesis (GO:0048858) | 498 | 12.56 | 5.59E-06 | 9.90E-03 |
| Cell part morphogenesis (GO:0032990) | 520 | 12.03 | 7.14E-06 | 1.14E-02 |
| Cell morphogenesis involved in neuron differentiation (GO:0048667) | 442 | 11.79 | 5.24E-05 | 4.91E-02 |
| Neuron projection development (GO:0031175) | 679 | 9.21 | 3.20E-05 | 3.92E-02 |
| Cell development (GO:0048468) | 1623 | 7.07 | 5.67E-08 | 2.26E-04 |
| Anatomical structure morphogenesis (GO:0009653) | 2177 | 4.79 | 1.07E-05 | 1.55E-02 |
| Cell differentiation (GO:0030154) | 3729 | 3.35 | 3.25E-05 | 3.70E-02 |
| Cellular developmental process (GO:0048869) | 3822 | 3.27 | 4.20E-05 | 4.18E-02 |
| Cellular component organization (GO:0016043) | 5620 | 3.15 | 1.01E-07 | 3.21E-04 |
| Cellular component organization or biogenesis (GO:0071840) | 5810 | 3.05 | 1.71E-07 | 4.54E-04 |
aReference gene list used for the analysis is from Homo sapiens.
bP-value was determined by Fisher’s Exact test.
cFDR is False Discovery rate.
Top diseases and bio functions affected in infected cells.
| Diseases and disorders (24 hpi) | Diseases and disorders (48 hpi) | ||
|---|---|---|---|
| Name | Name | ||
| Cancer | 4.8E-3–1.94E-12 | Neurological disease | 3.77E-4–5.08E-13 |
| Organismal injury and abnormalities | 4.8E-3–1.94E-12 | Organismal injury and abnormalities | 4.3E-4–5.08E-13 |
| Tumor morphology | 3.16E-3–1.94E-12 | Psychological disorders | 2.7E-4–5.08E-13 |
| Endocrine system disorders | 1.4E-3–1.33E-9 | Skeletal and muscular disorders | 3.15E-4–1.03E-12 |
| Infectious diseases | 1.3E-3–1.57E-7 | Infectious diseases | 3.77E-4–2.42E-11 |
| Molecular and cellular functions (24 hpi) | Molecular and cellular functions (48 hpi) | ||
| Name | Name | ||
| Protein synthesis | 1.3E-3–4.79E-36 | RNA post-transcriptional modification | 1.04E-5–2.92E-26 |
| RNA damage and repair | 2.18E-34–2.18E-34 | Cell death and survival | 4.1E-4–1.46E-20 |
| Cell death and survival | 1.87E-3–1.94E-12 | Gene expression | 3.14E-4–8.39E-13 |
| Gene expression | 4.11E-4–7.09E-10 | Cellular assembly and organization | 3.65E-4–1.03E-12 |
| Cellular development | 3.69E-3–2.64E-09 | Cellular function and maintenance | 3.77E-4–1.03E-12 |
| Physiological system development and function (24 hpi) | Physiological system development and function (48 hpi) | ||
| Name | Name | ||
| Embryonic development | 3.69E-3–9.02E-7 | Organismal survival | 4.53E-12–4.19E-12 |
| Connective tissue development | 3.55E-3–1.78E-6 | Nervous system development | 3.65E-4–4.14E-7 |
| Organismal survival | 3.14E-6–3.14E-6 | Tissue development | 4.18E-4–4.41E-7 |
| Nervous system development | 3.68E-3–3.47E-6 | Tissue morphology | 3.14E-4–1.34E-6 |
| Tissue development | 3.96E-3–3.47E-6 | Connective tissue development | 3.14E-4–1.34E-6 |
ap-Value calculated by Fisher’s Exact test.
Figure 3.Downstream Effect prediction on Ephrin signaling pathway by IPA. The gene expression data obtained by qPCR array in infected cells was overlaid on Ephrin signaling pathway using IPA. The biological functions affected by the gene expression changes was predicted using the Molecular Activity Predictor (MAP) tool in IPA. Proteins upregulated in the qPCR experiment are represented in shades of red and those that are downregulated are represented in shades of green, where the intensity of the shade is representative of the relative level of upregulation or downregulation. The proteins and downstream functions that are predicted to be activated or inhibited due to the observed gene expression changes are represented in shades of orange and blue respectively, where the intensity of the shade is representative of the relative level of activation or inhibition.
Figure 4.Downstream Effects prediction on PPAR signaling pathways by IPA. (a) The gene expression data observed by qPCR array in infected cells was overlaid on PPAR alpha signaling pathway using IPA. (b) The gene expression data observed by qPCR array in infected cells was overlaid on PPAR signaling pathway using IPA. The biological functions affected by the gene expression changes was predicted using the Molecular Activity Predictor (MAP) tool in IPA. Proteins upregulated in the qPCR experiment are represented in shades of red and those that are downregulated are represented in shades of green, where the intensity of the shade is representative of the relative level of upregulation or downregulation. The proteins and downstream functions that are predicted to be activated or inhibited due to the observed gene expression changes are represented in shades of orange and blue respectively, where the intensity of the shade is representative of the relative level of activation or inhibition.
Figure 5.Immunofluorescent staining to detect expression of PPAR signaling pathway genes in infected cells. (a) Protein-level expression of PPAR pathway genes was monitored by immunostaining with antibodies against FGR, APOC3 or HELZ2 (red) in ZIKV-infected and mock-infected ReNcell CX cells. Infected cells were identified by staining with antibody against ZIKV Envelope protein (green) and nuclei were stained using DAPI (blue). Scale bar is 100 µm. (b) Protein-level expression of PPAR pathway gene RXRG was monitored by immunostaining with antibodies against the protein (red) in ZIKV-infected and mock-infected ReNcell CX cells. Infected cells were identified by staining with antibody against ZIKV Envelope protein (green) and nuclei were stained using DAPI (blue). Scale bar is 100 µm. A 2X zoom of a specific region in the infected cell field of view is shown to indicate cytoplasmic staining of RXRG in infected cells. White arrows indicate cytoplasmic staining of the protein in infected cells and yellow arrows indicate RXRG staining limited to the nucleus in mock-infected cells.